Company / Capital Returned to Shareholders per Share
Viking Therapeutics, Inc. Capital Returned to Shareholders per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.09
FY2023
5-year range
$0.09 / $0.09
FY2019-FY2023
Trend
-0.0%
vs FY2022
Sector context
#41 of 51
Health Care
What the data says
Viking Therapeutics, Inc.'s capital returned to shareholders per share of $0.09 is lower than 80% of companies in the Health Care sector (FY2023). Improved from $0.00 to $0.09 over the past 7 years.
Based on SEC 10-K filings.
0.09 in FY2023.
Improved from $0.00 to $0.09 over the past 7 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 51This company $0.09 Sector average $2.74
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2023, capital returned to shareholders per share decreased 0.0% year-over-year.
- Ranks #41 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.09 | -0.0% |
| FY2022 | $0.09 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.00 | +1077.2% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026